Product logins

Find logins to all Clarivate products below.


Clarivate’s Pharma Industry Report provides pharma executives with a comprehensive summary of the current and future state of the global pharmaceutical industry.

Scope

This report pulls together key information about the global pharmaceutical market from across our Company & Drug Insights content. We analyze the top selling brands, companies, and therapeutic areas. We evaluate the leading competitors in terms of their ethical drug sales, strategic focus, current drivers, patent exposure, and pipeline projects. We compare the different therapeutic areas in terms of their global sales and highlight the leading competitors and pipeline drugs within each area to provide you with a comprehensive summary of the global market.

Companies Mentioned

  • AbbVie
  • Amgen
  • Astellas Pharma
  • AstraZeneca
  • Bayer
  • Biogen
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Daiichi-Sankyo
  • Eisai
  • Eli Lilly
  • Gilead
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck & Co
  • Merck KGaA
  • Novartis
  • Novo Nordisk
  • Otsuka
  • Pfizer
  • Roche
  • Sanofi
  • Takeda
  • Teva
  • Vertex

Questions answered in this report

  • Who are the leading competitors in the global pharmaceutical industry? What are their current drivers and areas of R&D? What is their timeline for patent exposure?
  • How do the different therapy areas rank in terms of size and relative growth? How do their global sales break down by drug technology, and what are the leading pipeline projects?
  • What are the leading drugs according to global sales, and how will these rankings change by 2028?

 

Related Market Assessment Reports

Report
Epilepsy – Unmet Need – Unmet Need – Dravet Syndrome (US/EU)
Dravet syndrome (DS) is a rare, severe, pediatric-onset genetic epileptic encephalopathy that typically emerges within the first year of life and is marked by developmental delays and multiple…
Report
Alzheimer’s Disease – Unmet Need – Unmet Need – Agitation in Alzheimer’s Disease (US/EU)
Agitation affects most Alzheimer’s disease (AD) patients and comprises a constellation of disruptive symptoms for patients and their families, which may contribute to nursing home placement…
Report
Breast Cancer – Unmet Need – Unmet Need – Metastatic HR-Positive / HER2-Negative Breast Cancer (US/EU)
The landscape of advanced HR-positive / HER2-negative breast cancer treatment is continually evolving. CDK4/6 inhibitors (Pfizer’s Ibrance, Novartis’s Kisqali, and Eli Lilly’s Verzenio)…
Report
Hepatitis B Virus – Geographic Focus: China – China In-Depth – Hepatitis B Virus
HBV is a major public health burden in China, with chronically infected individuals at a significantly increased risk of developing hepatic cirrhosis and hepatocellular carcinoma. Current treatment…
Report
Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia – Current Treatment – Current Treatment: Physician Insights – B-Cell Non-Hodgkin’s Lymphoma (US)
Non-Hodgkin’s lymphoma (NHL) represents a diverse group of hematological malignancies broadly classified into indolent and aggressive subtypes. Patients with aggressive NHL—diffuse large B-cell…